HLA-DR1/DR4 inhibitors (Provid)

N/A

Report date: 2025/03/20 15:14:37
NME

Base Information

Drug NameHLA-DR1/DR4 inhibitors (Provid)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistocompatibility antigens class II inhibitors
TargetsHistocompatibility antigens class II
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProvid Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesProvid Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A